BioCentury
ARTICLE | Company News

Dr. Reddy's, ICICI generics deal

March 29, 2005 1:54 AM UTC

RDY said ICICI Venture has agreed to pay $56 million to fund development and commercialization of undisclosed generic compounds in exchange for royalties. RDY said ICICI will fund development, registr...